Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xianjun Yu

Showing results (271-280 of 421) with videos related to

Pageof 43
Sort By:
Cancer Cell International|September 27, 2021
ALDOA inhibits cell cycle arrest induced by DNA damage via the ATM-PLK1 pathway in pancreatic cancer cellsHaidi Chen, Zeng Ye, Xiaowu Xu, et al.
Surgical Endoscopy|May 15, 2024
Evaluating the efficacy of laparoscopic radical antegrade modular pancreatosplenectomy in selected early-stage left-sided pancreatic cancer: a propensity score matching studyZheng Li, Wenyan Xu, Ting Wang, et al.
Translational Oncology|December 3, 2025
The CHPT-pSTAT3-SLC7A11 signaling axis controls progression and ferroptosis susceptibility of pancreatic cancerJianhui Yang, Jiang Liu, Zeyin Rong, et al.
International Journal of Cancer|February 17, 2017
Analysis of ctDNA to predict prognosis and monitor treatment responses in metastatic pancreatic cancer patientsHe Cheng, Chen Liu, Jiahao Jiang, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|October 4, 2016
Optimize CA19-9 in detecting pancreatic cancer by Lewis and Secretor genotypingGuopei Luo, Meng Guo, Kaizhou Jin, et al.
Aging|November 23, 2020
The value of a metabolic reprogramming-related gene signature for pancreatic adenocarcinoma prognosis predictionZhen Tan, Yubin Lei, Jin Xu, et al.
Redox Biology|December 3, 2020
FBW7-NRA41-SCD1 axis synchronously regulates apoptosis and ferroptosis in pancreatic cancer cellsZeng Ye, Qifeng Zhuo, Qiangsheng Hu, et al.
Cancer Management and Research|January 15, 2021
Fibrinogen/Albumin Ratio as a Promising Marker for Predicting Survival in Pancreatic Neuroendocrine NeoplasmsShengming Deng, Zhiyao Fan, Huanyu Xia, et al.
World Journal of Surgical Oncology|February 1, 2021
High GFPT1 expression predicts unfavorable outcomes in patients with resectable pancreatic ductal adenocarcinomaYitao Gong, Yunzhen Qian, Guopei Luo, et al.
International Journal of Cancer|March 9, 2023
EGFR is a potential therapeutic target for highly glycosylated and aggressive pancreatic neuroendocrine neoplasmsZhiwen Xiao, Huaxiang Xu, Jonathan R Strosberg, et al.
Pageof 43

Showing results (271-280 of 421) with videos related to

Sort By:
Pageof 43
Cancer Cell International|September 27, 2021
ALDOA inhibits cell cycle arrest induced by DNA damage via the ATM-PLK1 pathway in pancreatic cancer cellsHaidi Chen, Zeng Ye, Xiaowu Xu, et al.
Surgical Endoscopy|May 15, 2024
Evaluating the efficacy of laparoscopic radical antegrade modular pancreatosplenectomy in selected early-stage left-sided pancreatic cancer: a propensity score matching studyZheng Li, Wenyan Xu, Ting Wang, et al.
Translational Oncology|December 3, 2025
The CHPT-pSTAT3-SLC7A11 signaling axis controls progression and ferroptosis susceptibility of pancreatic cancerJianhui Yang, Jiang Liu, Zeyin Rong, et al.
International Journal of Cancer|February 17, 2017
Analysis of ctDNA to predict prognosis and monitor treatment responses in metastatic pancreatic cancer patientsHe Cheng, Chen Liu, Jiahao Jiang, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|October 4, 2016
Optimize CA19-9 in detecting pancreatic cancer by Lewis and Secretor genotypingGuopei Luo, Meng Guo, Kaizhou Jin, et al.
Aging|November 23, 2020
The value of a metabolic reprogramming-related gene signature for pancreatic adenocarcinoma prognosis predictionZhen Tan, Yubin Lei, Jin Xu, et al.
Redox Biology|December 3, 2020
FBW7-NRA41-SCD1 axis synchronously regulates apoptosis and ferroptosis in pancreatic cancer cellsZeng Ye, Qifeng Zhuo, Qiangsheng Hu, et al.
Cancer Management and Research|January 15, 2021
Fibrinogen/Albumin Ratio as a Promising Marker for Predicting Survival in Pancreatic Neuroendocrine NeoplasmsShengming Deng, Zhiyao Fan, Huanyu Xia, et al.
World Journal of Surgical Oncology|February 1, 2021
High GFPT1 expression predicts unfavorable outcomes in patients with resectable pancreatic ductal adenocarcinomaYitao Gong, Yunzhen Qian, Guopei Luo, et al.
International Journal of Cancer|March 9, 2023
EGFR is a potential therapeutic target for highly glycosylated and aggressive pancreatic neuroendocrine neoplasmsZhiwen Xiao, Huaxiang Xu, Jonathan R Strosberg, et al.
Pageof 43